1.76
Beyondspring Inc stock is traded at $1.76, with a volume of 26,529.
It is up +0.00% in the last 24 hours and down -5.88% over the past month.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
See More
Previous Close:
$1.76
Open:
$2.0205
24h Volume:
26,529
Relative Volume:
0.44
Market Cap:
$70.98M
Revenue:
$1.88M
Net Income/Loss:
$-15.57M
P/E Ratio:
-4.40
EPS:
-0.4
Net Cash Flow:
$-50.09M
1W Performance:
-12.87%
1M Performance:
-5.88%
6M Performance:
-1.68%
1Y Performance:
-7.12%
Beyondspring Inc Stock (BYSI) Company Profile
Name
Beyondspring Inc
Sector
Industry
Phone
646-528-4184
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BYSI
Beyondspring Inc
|
1.76 | 74.61M | 1.88M | -15.57M | -50.09M | -0.40 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-02-21 | Downgrade | BofA Securities | Buy → Underperform |
Dec-02-21 | Downgrade | Jefferies | Buy → Hold |
Dec-01-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
Dec-01-21 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-09-21 | Initiated | Robert W. Baird | Outperform |
Aug-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
Apr-05-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
Jan-11-21 | Initiated | BofA Securities | Buy |
Dec-29-20 | Initiated | Evercore ISI | Outperform |
Feb-07-20 | Initiated | Jefferies | Buy |
Jan-10-20 | Initiated | Nomura | Buy |
Dec-03-19 | Initiated | William Blair | Outperform |
Jul-10-19 | Reiterated | H.C. Wainwright | Buy |
Apr-30-19 | Downgrade | Maxim Group | Buy → Hold |
Oct-25-18 | Reiterated | Maxim Group | Buy |
View All
Beyondspring Inc Stock (BYSI) Latest News
Candlestick signals on BeyondSpring Inc. stock todayWeekly Profit Summary & Risk Managed Investment Strategies - Newser
What MACD and RSI say about BeyondSpring Inc.Market Performance Report & Weekly Sector Rotation Insights - Newser
Chart overlay techniques for tracking BeyondSpring Inc.Analyst Downgrade & Consistent Return Strategy Ideas - Newser
Will BeyondSpring Inc. benefit from macro trendsInflation Watch & Target Return Focused Picks - Newser
Institutional scanner results for BeyondSpring Inc.2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Real time scanner hits for BeyondSpring Inc. explainedMarket Sentiment Summary & Weekly Momentum Stock Picks - Newser
BeyondSpring (NASDAQ:BYSI) Releases Quarterly Earnings Results - MarketBeat
What recovery options are there for BeyondSpring Inc.Inflation Watch & Long Hold Capital Preservation Plans - Newser
Custom watchlist performance reports with BeyondSpring Inc.2025 Performance Recap & Community Verified Watchlist Alerts - Newser
Visual trend scoring systems applied to BeyondSpring Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Should you wait for a breakout in BeyondSpring Inc.Trade Risk Assessment & Smart Allocation Stock Tips - Newser
Market reaction to BeyondSpring Inc.’s recent newsGap Down & Low Risk Growth Stock Ideas - Newser
Using economic indicators to assess BeyondSpring Inc. potentialWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Statistical indicators supporting BeyondSpring Inc.’s strengthOptions Play & Free Community Supported Trade Ideas - Newser
Has BeyondSpring Inc. found a price floorJuly 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Using fundamentals and technicals on BeyondSpring Inc.Trade Ideas & Weekly High Momentum Picks - Newser
How to manage a losing position in BeyondSpring Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser
BeyondSpring Inc. stock volume spike explainedJuly 2025 Drop Watch & Intraday High Probability Alerts - Newser
Applying chart zones and confluence areas to BeyondSpring Inc.Market Volume Report & Daily Entry Point Trade Alerts - Newser
BeyondSpring (NASDAQ:BYSI) Shares Down 2%Time to Sell? - MarketBeat
Heatmap analysis for BeyondSpring Inc. and competitorsWeekly Earnings Recap & Weekly Return Optimization Alerts - Newser
Analyzing net buyer seller activity in BeyondSpring Inc.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - Newser
Will a bounce in BeyondSpring Inc. offer an exitJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser
BeyondSpring Reports Promising Clinical Results for Plinabulin in NSCLC Patients and Improved Q2 2025 Financials - AInvest
BeyondSpring Q2 2025: Promising Clinical Results and Strategic Moves - AInvest
Beyondspring Inc Stock (BYSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beyondspring Inc Stock (BYSI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Decheng Capital China Life Sci | 10% Owner |
Aug 19 '25 |
Sale |
1.77 |
3,604 |
6,379 |
1,922,900 |
Decheng Capital China Life Sci | 10% Owner |
Aug 20 '25 |
Sale |
1.74 |
3,456 |
6,013 |
1,919,444 |
Decheng Capital China Life Sci | 10% Owner |
Aug 15 '25 |
Sale |
2.00 |
2,900 |
5,800 |
1,974,172 |
Decheng Capital China Life Sci | 10% Owner |
Aug 14 '25 |
Sale |
2.00 |
2,000 |
4,000 |
1,977,072 |
Decheng Capital China Life Sci | 10% Owner |
Jun 20 '25 |
Sale |
3.15 |
285,217 |
898,286 |
935,000 |
Decheng Capital China Life Sci | 10% Owner |
Jun 18 '25 |
Sale |
3.17 |
59,253 |
187,832 |
1,844,326 |
Decheng Capital China Life Sci | 10% Owner |
Jul 17 '25 |
Sale |
2.19 |
20,572 |
45,053 |
894,830 |
Decheng Capital China Life Sci | 10% Owner |
Jul 08 '25 |
Sale |
2.29 |
9,059 |
20,745 |
925,017 |
Decheng Capital China Life Sci | 10% Owner |
Jun 17 '25 |
Sale |
3.23 |
5,000 |
16,150 |
995,000 |
Decheng Capital China Life Sci | 10% Owner |
Jul 16 '25 |
Sale |
2.24 |
5,396 |
12,087 |
915,402 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):